Hussamuddin Adwan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Hussamuddin Adwan has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
Brian Davidson
University Department of Surgery, University College London, Royal Free Hospital, London, UK
2 shared publications- Alexander Marcus Seifalian
Nanotechnology and Regenerative Medicine Commercialization Centre (NanoRegMed Ltd.), London BioScience Innovation Centre, London NW1 0NH, UK
1 shared publication Alice Barnes
West Suffolk Hospital NHS Foundation Trust, Bury St Edmunds, Suffolk, UK
1 shared publicationAlison Winstanley
Cellular Pathology, University College London Hospital
1 shared publication- Arin Saha
Department of General Surgery, Calderdale and Huddersfield NHS Foundation Trust, Huddersfield, Yorkshire, United Kingdom
1 shared publication - Ashraf S. Elmetwally
London Surgical Research Group
1 shared publication
Latest Publications
- Open Access
- 1 January 2024
- Published by XMLink in Journal of Metabolic and Bariatric Surgery
- Vol. 13 (2) , 50-58
Clinical Outcomes in Patients Undergoing Sequential Intragastric Balloon (IGB) Treatment for Super Obesity: A Single Centre Retrospective Analysis
Hammett F, et al. J Metab Bariatr Surg. 2024 Dec;13(2):50-58. https://doi.org/10.17476/jmbs.2024.13.2.50
- 1 January 2024
- Published by XMLink in Journal of Metabolic and Bariatric Surgery
- Vol. 13 (2) , 50-58
Open AccessClinical Outcomes in Patients Undergoing Sequential Intragastric Balloon (IGB) Treatment for Super Obesity: A Single Centre Retrospective Analysis
Hammett F, et al. J Metab Bariatr Surg. 2024 Dec;13(2):50-58. https://doi.org/10.17476/jmbs.2024.13.2.50
- 1 July 2014
- Published by Royal College of Surgeons of England in The Annals of The Royal College of Surgeons of England
- Vol. 96 (5) , 352-358
Use of the surgical Apgar score to guide postoperative care
Introduction: The surgical Apgar score (SAS) can predict 30-day major complications or death after surgery. Studies have validated the score in different patient populations and suggest it should be used to objectively guide postoperative care. We aimed to see whether using the SAS in a decisive approach in a future randomised controlled trial (RCT) would be likely to demonstrate an effect on postoperative care and clinical outcome. Methods: A total of 143 adults undergoing general/vascular surgery in 9 National Health Service hospitals were recruited to a pilot single blinded RCT and the data for 139 of these were analysed. Participants were randomised to a control group with standard postoperative care or to an intervention group with care influenced (but not mandated) by the SAS (decisive approach). The notional primary outcome was 30-day major complications or death. Results: Incidence of major complications was similar in both groups (control: 20/69 [29%], intervention: 23/70 [33%], p=0.622). Immediate admissions to the critical care unit was higher in the intervention group, especially in the SAS 0–4 subgroup (4/6 vs 2/7) although this was not statistically significant (p=0.310). Validity was also confirmed in area under the curve (AUC) analysis (AUC: 0.77). Conclusions: This pilot study found that a future RCT to investigate the effect of using the SAS in a decisive approach may demonstrate a difference in postoperative care. However, significant changes to the design are needed if differences in clinical outcome are to be achieved reliably. These would include a wider array of postoperative interventions implemented using a quality improvement approach in a stepped wedge cluster design with blinded collection of outcome data.
- 1 July 2014
- Published by Royal College of Surgeons of England in The Annals of The Royal College of Surgeons of England
- Vol. 96 (5) , 352-358
Use of the surgical Apgar score to guide postoperative care
Introduction: The surgical Apgar score (SAS) can predict 30-day major complications or death after surgery. Studies have validated the score in different patient populations and suggest it should be used to objectively guide postoperative care. We aimed to see whether using the SAS in a decisive approach in a future randomised controlled trial (RCT) would be likely to demonstrate an effect on postoperative care and clinical outcome. Methods: A total of 143 adults undergoing general/vascular surgery in 9 National Health Service hospitals were recruited to a pilot single blinded RCT and the data for 139 of these were analysed. Participants were randomised to a control group with standard postoperative care or to an intervention group with care influenced (but not mandated) by the SAS (decisive approach). The notional primary outcome was 30-day major complications or death. Results: Incidence of major complications was similar in both groups (control: 20/69 [29%], intervention: 23/70 [33%], p=0.622). Immediate admissions to the critical care unit was higher in the intervention group, especially in the SAS 0–4 subgroup (4/6 vs 2/7) although this was not statistically significant (p=0.310). Validity was also confirmed in area under the curve (AUC) analysis (AUC: 0.77). Conclusions: This pilot study found that a future RCT to investigate the effect of using the SAS in a decisive approach may demonstrate a difference in postoperative care. However, significant changes to the design are needed if differences in clinical outcome are to be achieved reliably. These would include a wider array of postoperative interventions implemented using a quality improvement approach in a stepped wedge cluster design with blinded collection of outcome data.
- 1 February 2014
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 49 (2) , 277-279
Laparoscopic versus open appendicectomy in children: A UK District General Hospital experience
- 1 February 2014
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 49 (2) , 277-279
Laparoscopic versus open appendicectomy in children: A UK District General Hospital experience
- Open Access
- 11 December 2013
- Published by Wiley in HPB Surgery
- Vol. 2013, 1-5
Partial Preservation of Segment IV Confers No Benefit When Performing Extended Right Hepatectomy for Colorectal Liver Metastases
Introduction. Reducing the volume of resected liver parenchyma may lead to lower morbidity and mortality. The aim of this study was to determine whether partial preservation of segment IV leads to improved outcomes when undertaking extended right hepatectomy for colorectal liver metastases (CRLM). Materials and Methods. A retrospective analysis of patients undergoing right-sided hepatectomy for CRLM was performed. Rates of 90-day mortality and organ dysfunction were compared in 117 patients undergoing right hepatectomy , partially extended right hepatectomy with preservation of part of segment IV , and fully extended right hepatectomy . Results. The 90-day mortality rate of those undergoing right hepatectomy (3/85) was similar to that of those undergoing extended right hepatectomy (0/12) but lower than that of those undergoing partially extended right hepatectomy (4/20) . The rates of hepatic and renal dysfunction were similar between patients undergoing right hepatectomy, partially extended or extended hepatectomy. Discussion. Preservation of part of segment IV confers little clinical benefit when performing extended right hepatectomy for CRLM.
- 11 December 2013
- Published by Wiley in HPB Surgery
- Vol. 2013, 1-5
Open AccessPartial Preservation of Segment IV Confers No Benefit When Performing Extended Right Hepatectomy for Colorectal Liver Metastases
Introduction. Reducing the volume of resected liver parenchyma may lead to lower morbidity and mortality. The aim of this study was to determine whether partial preservation of segment IV leads to improved outcomes when undertaking extended right hepatectomy for colorectal liver metastases (CRLM). Materials and Methods. A retrospective analysis of patients undergoing right-sided hepatectomy for CRLM was performed. Rates of 90-day mortality and organ dysfunction were compared in 117 patients undergoing right hepatectomy , partially extended right hepatectomy with preservation of part of segment IV , and fully extended right hepatectomy . Results. The 90-day mortality rate of those undergoing right hepatectomy (3/85) was similar to that of those undergoing extended right hepatectomy (0/12) but lower than that of those undergoing partially extended right hepatectomy (4/20) . The rates of hepatic and renal dysfunction were similar between patients undergoing right hepatectomy, partially extended or extended hepatectomy. Discussion. Preservation of part of segment IV confers little clinical benefit when performing extended right hepatectomy for CRLM.
- Open Access
- 24 April 2012
- Published by SAGE Publications in Journal of Biomaterials Applications
- Vol. 28 (2) , 250-261
Modifying three-dimensional scaffolds from novel nanocomposite materials using dissolvable porogen particles for use in liver tissue engineering
Background: Although hepatocytes have a remarkable regenerative power, the rapidity of acute liver failure makes liver transplantation the only definitive treatment. Attempts to incorporate engineered three-dimensional liver tissue in bioartificial liver devices or in implantable tissue constructs, to treat or bridge patients to self-recovery, were met with many challenges, amongst which is to find suitable polymeric matrices. We studied the feasibility of utilising nanocomposite polymers in three-dimensional scaffolds for hepatocytes. Materials and methods: Hepatocytes (HepG2) were seeded on a flat sheet and in three-dimensional scaffolds made of a nanocomposite polymer (Polyhedral Oligomeric Silsesquioxane [POSS]-modified polycaprolactone urea urethane) alone as well as with porogen particles, i.e. glucose, sodium bicarbonate and sodium chloride. The scaffold architecture, cell attachment and morphology were studied with scanning electron microscopy, and we assessed cell viability and functionality. Results: Cell attachment to the scaffolds was demonstrated. The scaffold made with glucose particles as porogen showed a narrower range of pore size with higher porosity and better inter-pore communications and seemed to encourage near normal cell morphology. There was a steady increase of albumin secretion throughout the experiment while the control (monolayer cell culture) showed a steep decrease after day 7. At the end of the experiment, there was no significant difference in viability and functionality between the scaffolds and the control. Conclusion: In this initial study, porogen particles were used to modify the scaffolds produced from the novel polymer. Although there was no significance against the control in functionality and viability, the demonstrable attachment on scanning electron microscopy suggest potential roles for this polymer and in particular for scaffolds made with glucose particles in liver tissue engineering.
- 24 April 2012
- Published by SAGE Publications in Journal of Biomaterials Applications
- Vol. 28 (2) , 250-261
Open AccessModifying three-dimensional scaffolds from novel nanocomposite materials using dissolvable porogen particles for use in liver tissue engineering
Background: Although hepatocytes have a remarkable regenerative power, the rapidity of acute liver failure makes liver transplantation the only definitive treatment. Attempts to incorporate engineered three-dimensional liver tissue in bioartificial liver devices or in implantable tissue constructs, to treat or bridge patients to self-recovery, were met with many challenges, amongst which is to find suitable polymeric matrices. We studied the feasibility of utilising nanocomposite polymers in three-dimensional scaffolds for hepatocytes. Materials and methods: Hepatocytes (HepG2) were seeded on a flat sheet and in three-dimensional scaffolds made of a nanocomposite polymer (Polyhedral Oligomeric Silsesquioxane [POSS]-modified polycaprolactone urea urethane) alone as well as with porogen particles, i.e. glucose, sodium bicarbonate and sodium chloride. The scaffold architecture, cell attachment and morphology were studied with scanning electron microscopy, and we assessed cell viability and functionality. Results: Cell attachment to the scaffolds was demonstrated. The scaffold made with glucose particles as porogen showed a narrower range of pore size with higher porosity and better inter-pore communications and seemed to encourage near normal cell morphology. There was a steady increase of albumin secretion throughout the experiment while the control (monolayer cell culture) showed a steep decrease after day 7. At the end of the experiment, there was no significant difference in viability and functionality between the scaffolds and the control. Conclusion: In this initial study, porogen particles were used to modify the scaffolds produced from the novel polymer. Although there was no significance against the control in functionality and viability, the demonstrable attachment on scanning electron microscopy suggest potential roles for this polymer and in particular for scaffolds made with glucose particles in liver tissue engineering.
- 23 March 2011
- Published by Wiley in Digestive Endoscopy
- Vol. 23 (2) , 199-200
SPYGLASS CHOLANGIOSCOPY IN THE EVALUATION OF AN INTRA-HEPATIC BILIARY LESION
- 23 March 2011
- Published by Wiley in Digestive Endoscopy
- Vol. 23 (2) , 199-200
SPYGLASS CHOLANGIOSCOPY IN THE EVALUATION OF AN INTRA-HEPATIC BILIARY LESION
- Open Access
- 7 May 2008
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 3 (1) , 27
Interventional bronchoscopy for benign tracheobronchial diseases under cardiopulmonary bypass support: case reports and literature review
The use of cardiopulmonary bypass as an adjunct to airway surgery for non-malignant diseases in adults is not well established in the UK. We are reporting two cases which demonstrate the additional benefits of using cardiopulmonary bypass during difficult bronchoscopy and complex airway stenting. The first case presents an emergency indication for cardiopulmonary bypass in a life-threatening but benign condition. The second case presented, utilises cardiopulmonary bypass standby as adjunct to a potentially life threatening procedure. A review of the literature is also provided.
- 7 May 2008
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 3 (1) , 27
Open AccessInterventional bronchoscopy for benign tracheobronchial diseases under cardiopulmonary bypass support: case reports and literature review
The use of cardiopulmonary bypass as an adjunct to airway surgery for non-malignant diseases in adults is not well established in the UK. We are reporting two cases which demonstrate the additional benefits of using cardiopulmonary bypass during difficult bronchoscopy and complex airway stenting. The first case presents an emergency indication for cardiopulmonary bypass in a life-threatening but benign condition. The second case presented, utilises cardiopulmonary bypass standby as adjunct to a potentially life threatening procedure. A review of the literature is also provided.
- 29 February 2008
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 43 (2) , 341-343
Are routine chest radiographs needed after fluoroscopically guided percutaneous insertion of central venous catheters in children?
- 29 February 2008
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 43 (2) , 341-343
Are routine chest radiographs needed after fluoroscopically guided percutaneous insertion of central venous catheters in children?
- 1 November 2004
- Published by Royal College of Surgeons of England in The Annals of The Royal College of Surgeons of England
- Vol. 86 (6) , 1-3
A solitary encapsulated pelvic aggressive angiomyxoma
Aggressive angiomyxoma (AAM) was first reported in 1983 as a distinct, slow growing, benign but locally infiltrative, soft tissue tumour. It usually arises in the pelvic and perineal organs, mostly in women. A 47-year-old woman was found to have a large encapsulated retroperitoneal aggressive angiomyxoma. The mass was completely excised via abdomino-perineal approach, and no recurrence noted on MRI at 19 months' follow-up. The encapsulation of this tumour together with other reported rare presentations, suggest an isolated mesenchymal cell origin. A review of the literature is provided.
- 1 November 2004
- Published by Royal College of Surgeons of England in The Annals of The Royal College of Surgeons of England
- Vol. 86 (6) , 1-3
A solitary encapsulated pelvic aggressive angiomyxoma
Aggressive angiomyxoma (AAM) was first reported in 1983 as a distinct, slow growing, benign but locally infiltrative, soft tissue tumour. It usually arises in the pelvic and perineal organs, mostly in women. A 47-year-old woman was found to have a large encapsulated retroperitoneal aggressive angiomyxoma. The mass was completely excised via abdomino-perineal approach, and no recurrence noted on MRI at 19 months' follow-up. The encapsulation of this tumour together with other reported rare presentations, suggest an isolated mesenchymal cell origin. A review of the literature is provided.